Surfactant function in children with chronic airway inflammation

Journal of Applied Physiology

Volumn 97, Issue 6, 2004, Pages 2160-2165

  Braun, A ^a   Steinecker, M ^a   Schumacher, S ^a   Griese, M ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Airways; Capillary surfactometer; Chronic bronchitis; Pulmonary surfactant; Tracheostomy

Indexed keywords

LUNG SURFACTANT;

AIRWAY OBSTRUCTION; ARTICLE; CHRONIC BRONCHITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; LUNG LAVAGE; MALE; NEUTROPHIL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN TRANSPORT; SCHOOL CHILD; SUPERNATANT; TRACHEOSTOMY;

BRONCHITIS, CHRONIC; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; NEUTROPHILS; PHOSPHOLIPIDS; PNEUMONIA; PULMONARY SURFACTANTS; TRACHEOSTOMY;

EID: 9244225171     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00523.2004     Document Type: Article

References (32)

1. 2 and eosinophil lysophospholipases causes surfactant dysfunction: a mechanism for small airway closure in asthma. Chest 123: 355S, 2003.
2. Bligh EG and Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
3. Bouhafs RK and Jarstrand C. Effects of antioxidants on surfactant peroxidation by stimulated human polymorphonuclear leukocytes. Free Radic Res 36: 727-734, 2002.
4. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
5. Cheng G, Ueda T, Sugiyama K, Toda M, and Fukuda T. Compositional and functional changes of pulmonary surfactant in a guinea-pig model of chronic asthma. Respir Med 95: 180-186, 2001.
6. Dargaville PA, South M, and McDougall PN. Surfactant abnormalities in infants with severe viral bronchiolitis. Arch Dis Child 75: 133-136, 1996.
7. Duck-Chong CG. A rapid sensitive method for determining phospholipid phosphorus involving digestion with magnesium nitrate. Lipids 14: 492-497, 1979.
8. Enhorning G. Pulmonary surfactant function studied with the pulsating bubble surfactometer (PBS) and the capillary surfactometer (CS). Comp Biochem Physiol A 129: 221-226, 2001.
9. Gel'tser BI and Maidanov IV. The functional activity of pulmonary surfactant in chronic bronchitis. Ter Arkh 69: 9-12, 1997.
10. Gregory TJ, Longmore WJ, Moxley M, Whitsett JA, Reed CR, and Fowler AA. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 88: 1976-1981, 1991.
11. Griese M. Pulmonary surfactant in health and lung diseases: state of the art. Eur Respir J 13: 1455-1476, 1999.
12. Griese M, Birrer P, and Demirsoy A. Pulmonary surfactant in cystic fibrosis. Eur Respir J 10: 1983-1988, 1997.
13. Griese M, Dietrich P, Potz C, Westerburg B, Bals R, and Reinhardt D. Surfactant subfractions during nosocomial infection in ventilated preterm human neonates. Am J Respir Crit Care Med 153: 398-403, 1996.
14. Griese M, Felber J, Reiter K, Strong P, Reid K, Belohradsky BH, Jäger G, and Nicolai T. Airway inflammation in children with tracheostomy. Pediatr Pulmonol 37: 361, 2004.
15. Griese M, Neumann M, von Bredow T, Schmidt R, and Ratjen F. Surfactant in children with malignancies, immunosuppression, fever and pulmonary infiltrates. Eur Respir J 20: 1284-1291, 2002.
16. Gunther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, and Seeger W. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 153: 176-184, 1996.
17. Hohlfeld JM, Ahlf K, Enhorning G, Balke K, Erpenbeck VJ, Petschallies J, Hoymann HG, Fabel H, and Krug N. Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge. Am J Respir Crit Care Med 159: 1803-1809, 1999.
18. Holm BA and Notter RH. Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity. J Appl Physiol 63: 1434-1442, 1987.
19. Horsfield K. Diameters, generations, and orders of branches in the bronchial tree. J Appl Physiol 68: 457-461, 1990.
20. Jarjour NN and Enhorning G. Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant. Am J Respir Crit Care Med 160: 336-341, 1999.
21. Jayaraman S, Song Y, Vetrivel LSL, and Verkman AS. Non-invasive in vivo fluorescence measurement of airway-susrface liquid depth, salt concentration and pH. J Clin Invest 107: 317-324, 2001.
22. Keough KW, Parsons CS, and Tweeddale MG. Interactions between plasma proteins and pulmonary surfactant: pulsating bubble studies. Can J Physiol Pharmacol 67: 663-668, 1989.
23. Liau DF, Yin NX, Huang J, and Ryan SF. Effects of human polymorphonuclear leukocyte elastase upon surfactant proteins in vitro. Biochim Biophys Acta 1302: 117-128, 1996.
24. Liu M, Wang L, and Enhorning G. Surfactant dysfunction develops when the immunized guinea-pig is challenged with ovalbumin aerosol. Clin Exp Allergy 25: 1053-1060, 1995.
25. Liu M, Wang L, Holm BA, and Enhorning G. Dysfunction of guinea-pig pulmonary surfactant and type 11 pneumocytes after repetitive challenge with aerolized ovalbumin. Clin Exp Allergy 27: 802-807, 1997.
26. Liu M, Wang L, Li E, and Enhorning G. Pulmonary surfactant will secure free airflow through a narrow tube. J Appl Physiol 71: 742-748, 1991.
27. Macklem PT, Proctor DF, and Hogg JC. The stability of peripheral airways. Respir Physiol 8: 191-203, 1970.
28. Mander A, Langton-Hewer S, Bernhard W, Warner JO, and Postle AD. Altered phospholipid composition and aggregate structure of lung surfactant is associated with impaired lung function in young children with respiratory infections. Am J Respir Cell Mol Biol 27: 714-721, 2002.
29. Ueda T, Cheng G, Kuroki Y, Sano H, Sugiyama K, Motojima S, and Fukuda T. Effects of aging on surfactant forms in rats. Eur Respir J 15: 80-84, 2000.
30. Ward C, Duddridge M, Fenwick J, Gardiner PV, Fleetwood A, Hendrick DJ, and Walters EH. Evaluation of albumin as a reference marker of dilution in bronchoalveolar lavage fluid from asthmatics and control subjects. Thorax 48: 518-522, 1993.
31. Ward C, Fenwick J, Booth H, and Walters EH. Albumin is not suitable as a marker of bronchoalveolar lavage dilution in interstitial lung disease. Eur Respir J 10: 2029-2033, 1997.
32. Wright SM, Hockey PM, Enhorning G, Strong P, Reid KBM, Holgate ST, Djukanovic R, and Postle AD. Altered airway surfactant phospholipid composition and reduced lung function in asthma. J Appl Physiol 89: 1283-1292, 2000.